NOTCH1 mutations with gain of function are present in approximately 20% of ACC cases, and are associated with more aggressive phenotypes, increased tendency to metastasize, and an overall shorter survival [59]. The gene discussed is NOTCH1; the disease is adrenal cortex carcinoma.